Characterization and engineering of Drosophila melanogaster β1-3-galactosyltransferase for glycoengineering applications

  • 0School of Biological Engineering, Dalian Polytechnic University, Dalian, 116034, China; School of Health and Life Sciences, University of Health and Rehabilitation Sciences, Qingdao, 266113, China; National Glycoengineering Research Center and Shandong Provincial Key Laboratory of Carbohydrate Chemistry and Glycobiology, and State Key Laboratory of Microbial Technology, Shandong University, Qingdao, 266237, China.

|

|

Summary

This summary is machine-generated.

High-yield expression of Drosophila melanogaster β1-3-Galactosyltransferase (DmC1GalT1) was achieved. This enzyme is crucial for O-glycan synthesis and engineering, with key residues identified for substrate specificity.

Area Of Science

  • Biochemistry
  • Glycobiology
  • Enzymology

Background

  • β1-3-Galactosyltransferase from Drosophila melanogaster (DmC1GalT1) is vital for O-glycan synthesis.
  • DmC1GalT1 has significant potential in glycoengineering applications.

Purpose Of The Study

  • To achieve high-yield expression and purification of DmC1GalT1 in Escherichia coli.
  • To characterize the enzyme's substrate specificity and identify key residues for activity and stability.
  • To engineer DmC1GalT1 variants for synthetic glycobiology.

Main Methods

  • High-yield expression and purification of DmC1GalT1 in E. coli.
  • Enzyme activity assays with various glycopeptides and nucleotide sugars.
  • Site-directed mutagenesis and structural analysis.
  • Thermal stability predictions using ProStab.

Main Results

  • Over 5 mg/L of purified DmC1GalT1 was obtained.
  • The enzyme showed strict donor specificity for UDP-Gal and galactosylated human CD74-derived Tn-glycopeptides.
  • Mutagenesis studies identified residues N108 and Y325 as critical for donor recognition and specificity.
  • Engineered variants exhibited altered activity, stability, and substrate utilization profiles.

Conclusions

  • An efficient platform for DmC1GalT1 expression, characterization, and engineering was established.
  • Key residues influencing donor recognition were identified, enabling targeted engineering.
  • This work facilitates the development of tailored glycosyltransferase variants for synthetic glycobiology.